BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6927126)

  • 1. Gentamicin disposition in children with chronic renal failure.
    Berry PL; Kearns GL; Brown RD; Ritschel WA; Thompson GA; McEnery PT
    Pediatr Pharmacol (New York); 1982; 2(4):257-73. PubMed ID: 6927126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics of dibekacin in normal subjects and in patients with renal failure.
    Arancibia A; Chávez J; Ibarra R; Ruiz I; Icarte A; Thambo S; Chávez H
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):38-43. PubMed ID: 3557728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin pharmacokinetics during hemodialysis in patients suffering from chronic renal failure.
    Létourneau-Saheb L; Lapierre L; Daigneault R; Prud'Homme M; St-Louis G; Serois G
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):116-20. PubMed ID: 844930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis.
    Sojka JE; Brown SA
    J Am Vet Med Assoc; 1986 Oct; 189(7):784-9. PubMed ID: 3771340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age and renal function on gentamicin pharmacokinetic parameters.
    el-Sayed YM; Islam SI
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):503-9. PubMed ID: 2583877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of dibekacin in patients with renal failure and in patients undergoing hemodialysis.
    Arancibia A; Baillarie D; Bravo M; Chávez J
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):623-7. PubMed ID: 8688988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatinine clearance estimation from serum creatinine values: evaluation and comparison of five prediction formulae in Nigerian patients.
    Sanusi AA; Akinsola A; Ajayi AA
    Afr J Med Med Sci; 2000 Mar; 29(1):7-11. PubMed ID: 11379474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of thyroid function on the pharmacokinetics of gentamicin in pigs.
    Riond JL; Dix LP; Riviere JE
    Am J Vet Res; 1986 Oct; 47(10):2141-6. PubMed ID: 3777637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
    Leader WG; Tsubaki T; Chandler MH
    Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of gentamicin in the juvenile dog.
    Riviere JE; Coppoc GL
    Am J Vet Res; 1981 Sep; 42(9):1621-3. PubMed ID: 7325472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function.
    Platt DR; Matthews SJ; Sevka MJ; Comer JB; Quintiliani R; Cunha BA; Nightingale CH; Chow MS
    Clin Pharm; 1982; 1(4):361-5. PubMed ID: 7185531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical pharmacokinetic techniques for drug consultation and evaluation. IV: Gentamicin blood level versus time profiles of various dosage regimens recommended for renal impairment.
    Schumacher GE
    Am J Hosp Pharm; 1975 Mar; 32(3):299-308. PubMed ID: 1136979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.
    Wu MJ; Ing TS; Soung LS; Daugirdas JT; Hano JE; Gandhi VC
    Clin Nephrol; 1982 Jan; 17(1):19-23. PubMed ID: 7035042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of spirapril and spiraprilat in patients with chronic renal failure.
    Stein G; Sierakowski B; Grass P; Haufe CC; Jansa U; Weidinger G
    Blood Press Suppl; 1994; 2():47-53. PubMed ID: 8061846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.